The duocarmycins are anti-tumour antibiotics that derive their biological activity through sequence-selective alkylation of the minor groove of duplex DNA. A series of duocarmycin analogues including deshydroxy CI (l,2,7,7a-tetrahydrocyclopropa[c] indol-4-one) and CBI (l,2,9,9a-tetrahydrocyclopropa[c]benz[c]indol-4-one) derivatives were synthesised as potential bio-oxidatively activated prodrugs via Cytochrome P450 mixed function oxidase mediated hydroxylation. A number of isoforms of cytochrome P450 are expressed in tumours and could be used as the basis for tumour selective deshydroxy duocarmycin prodrug activation. Synthesis of the deactivated alkylation subunits of the prodrugs utilised an intramolecular 5-exo-trig free-radical cyclisat...
It is accepted that neoplastic diseases are related to gene alteration or oncogene activation. In pa...
The CC-1065 and duocarmycin family of compounds are ultrapotent antitumour antibiotics which demonst...
CC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antibiot...
(+)-CC-1065 and the duocarmycins are potent antitumor natural products which exert their antitumor e...
The design, synthesis, and evaluation of a predictably more potent analog of CC-1065 entailing the s...
The duocarmycins are a family of natural products first described in 1978 with the discovery of CC-1...
YesThe duocarmycins are potent antitumour agents with potential in the development of antibody drug...
yesCC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antib...
NoDuocarmycin natural products are promising anti-cancer cytotoxins but too potent for systemic use....
The synthesis of 1,2,8,8a-tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one (CPI), the parent CC-...
The design, synthesis, and evaluation of a predictably more potent analogue of CC-1065 entailing the...
Herkömmliche Zytostatika greifen vornehmlich in den Zellzyklus ein und somit werden Zellen mit hoher...
The family is characterised by a common spirocyclopropylcyclohexadienone pharmacophore. This unusual...
YesA library of duocarmycin bioprecursors based on the CPI and CBI scaffolds was synthesized and use...
The duocarmycins and (+)-CC-1065 are amongst the most potent antitumour antibiotics discovered to da...
It is accepted that neoplastic diseases are related to gene alteration or oncogene activation. In pa...
The CC-1065 and duocarmycin family of compounds are ultrapotent antitumour antibiotics which demonst...
CC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antibiot...
(+)-CC-1065 and the duocarmycins are potent antitumor natural products which exert their antitumor e...
The design, synthesis, and evaluation of a predictably more potent analog of CC-1065 entailing the s...
The duocarmycins are a family of natural products first described in 1978 with the discovery of CC-1...
YesThe duocarmycins are potent antitumour agents with potential in the development of antibody drug...
yesCC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antib...
NoDuocarmycin natural products are promising anti-cancer cytotoxins but too potent for systemic use....
The synthesis of 1,2,8,8a-tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one (CPI), the parent CC-...
The design, synthesis, and evaluation of a predictably more potent analogue of CC-1065 entailing the...
Herkömmliche Zytostatika greifen vornehmlich in den Zellzyklus ein und somit werden Zellen mit hoher...
The family is characterised by a common spirocyclopropylcyclohexadienone pharmacophore. This unusual...
YesA library of duocarmycin bioprecursors based on the CPI and CBI scaffolds was synthesized and use...
The duocarmycins and (+)-CC-1065 are amongst the most potent antitumour antibiotics discovered to da...
It is accepted that neoplastic diseases are related to gene alteration or oncogene activation. In pa...
The CC-1065 and duocarmycin family of compounds are ultrapotent antitumour antibiotics which demonst...
CC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antibiot...